Nasdaq-listed drugs company NeuroSearch has agreed to sell its 30.1% stake in medical technology maker Sophion Bioscience.
Biolin Scientific, a Sweden based peer backed by private equity firm Ratos, has acquired the Sophion stake from NeuroSeach for an undisclosed amount.